A systematic review of the effectiveness and cost-effectiveness of palivizumab (Synagis) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection

by Sue Simpson

No reviews yet
First published: 2001 1 language ISBN: 0704423219

Reviews

Log in or sign up to write a review.

No reviews yet. Be the first!


More by Sue Simpson


You Might Also Like

More in Cost of
Tax administration

Tax administration

United States. General Accounting Office
U.S. Postal Service

U.S. Postal Service

United States. General Accounting Office
Nuclear waste

Nuclear waste

United States. General Accounting Office
Financial Management

Financial Management

United States. General Accounting Office